The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling
Open accessAbstract
BACKGROUND: The existing estimate of the global burden of latent TB infection (LTBI) as "one-third" of the world population is nearly 20 y old. Given the importance of controlling LTBI as part of the End TB Strategy for eliminating TB by 2050, changes in demography and scientific understanding, and progress in TB control, it is important to re-assess the global burden of LTBI. METHODS AND FINDINGS: We constructed trends in annual risk in infection (ARI) for countries between 1934 and 2014 using a combination of direct estimates of ARI from LTBI surveys (131 surveys from 1950 to 2011) and indirect estimates of ARI calculated from World Health Organisation (WHO) estimates of smear positive TB prevalence from 1990 to 2014. Gaussian process regression was used to generate ARIs for country-years without data and to represent uncertainty. Estimated ARI time-series were applied to the demography in each country to calculate the number and proportions of individuals infected, recently infected (infected within 2 y), and recently infected with isoniazid (INH)-resistant strains. Resulting estimates were aggregated by WHO region. We estimated the contribution of existing infections to TB incidence in 2035 and 2050. In 2014, the global burden of LTBI was 23.0% (95% uncertainty interval [UI]: 20.4%-26.4%), amounting to approximately 1.7 billion people. WHO South-East Asia, Western-Pacific, and Africa regions had the highest prevalence and accounted for around 80% of those with LTBI. Prevalence of recent infection was 0.8% (95% UI: 0.7%-0.9%) of the global population, amounting to 55.5 (95% UI: 48.2-63.8) million individuals currently at high risk of TB disease, of which 10.9% (95% UI:10.2%-11.8%) was isoniazid-resistant. Current LTBI alone, assuming no additional infections from 2015 onwards, would be expected to generate TB incidences in the region of 16.5 per 100,000 per year in 2035 and 8.3 per 100,000 per year in 2050. Limitations included the quantity and methodological heterogeneity of direct ARI data, and limited evidence to inform on potential clearance of LTBI. CONCLUSIONS: We estimate that approximately 1.7 billion individuals were latently infected with Mycobacterium tuberculosis (M.tb) globally in 2014, just under a quarter of the global population. Investment in new tools to improve diagnosis and treatment of those with LTBI at risk of progressing to disease is urgently needed to address this latent reservoir if the 2050 target of eliminating TB is to be reached.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An estimated 1.7 billion have tuberculosis infections that are “latent.”56”
From Global health 2050: the path to halving premature death by mid-century (2024) · cites this paper as [56]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dye, C., Scheele, S., >Dolin, P., Pathania, V. S., Raviglione, M. C., & for the WHO Global Surveillance and Monitoring Project (1999) · JAMA · doi:10.1001/jama.282.7.677 · Cited by 2,955
The Growing Burden of Tuberculosis: Global Trends and Interactions With the HIV Epidemic
Corbett, E. L., Watt, C. J., Walker, N., Maher, D., Williams, B. G., Raviglione, M. C., & Dye, C. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.9.1009 · Cited by 2,553
Uplekar, M., Weil, D., Lonnroth, K., Jaramillo, E., Lienhardt, C., Dias, H. M., Falzon, D., Floyd, K., Gargioni, G., Getahun, H., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60570-0 · Cited by 1,117
Trunz, B. B., Fine, P., & Dye, C. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68507-3 · Cited by 1,114
Gamma Interferon Release Assays for Detection of Mycobacterium tuberculosis Infection
Pai, M., Denkinger, C. M., Kik, S. V., Rangaka, M. X., Zwerling, A. A., Oxlade, O., Metcalfe, J. Z., Cattamanchi, A., Dowdy, D. W., Dheda, K. U. J., et al. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00034-13 · Cited by 881
A blood RNA signature for tuberculosis disease risk: a prospective cohort study
Zak, D. E., Penn‐Nicholson, A., Scriba, T. J., Thompson, E. G., Suliman, S., Amon, L. M., Mahomed, H., Erasmus, M., Whatney, W. E., Hussey, G. D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01316-1 · Cited by 779
Latent Mycobacterium tuberculosis Infection
Getahun, H., Matteelli, A., Chaisson, R. E., & Raviglione, M. C. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1405427 · Cited by 776
Vynnycky, E., & Fine, P. (1997) · Epidemiology and Infection · doi:10.1017/s0950268897007917 · Cited by 562
Rangaka, M. X., Wilkinson, K. A., Glynn, J. R., Ling, D. I., Menzies, D., Mwansa-Kambafwile, J. R. M., Fielding, K., Wilkinson, R. J., & Pai, M. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70210-9 · Cited by 475
Burden of childhood tuberculosis in 22 high-burden countries: a mathematical modelling study
Dodd, P. J., Gardiner, E., Coghlan, R., & Seddon, J. A. (2014) · The Lancet Global Health · doi:10.1016/s2214-109x(14)70245-1 · Cited by 368
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 1,001
Assefa, Y. A., Gelaw, Y. A., Woldeyohannes, S. M., Hamada, Y., & Getahun, H. (2018) · European Respiratory Journal · doi:10.1183/13993003.00395-2018 · Cited by 26
Kewcharoenwong, C., Prabowo, S. A., Bancroft, G. J., Fletcher, H. A., & Lertmemongkolchai, G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02109 · Cited by 25
Trends in tuberculosis mortality in Brazil (1990-2015): joinpoint analysis
de Souza, C. D. F., de Paiva, J. P. S., da Silva, L. F., Leal, T. C., & Magalhães, M. D. A. F. M. (2019) · Jornal Brasileiro de Pneumologia · doi:10.1590/1806-3713/e20180393 · Cited by 26
Chekesa, B., Gumi, B., Chanyalew, M., Zewude, A., & Ameni, G. (2020) · PLoS ONE · doi:10.1371/journal.pone.0233314 · Cited by 26
Zhang, H., Wang, L., Li, F., Lu, S., & Xia, J. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-05413-9 · Cited by 26
Gelder, R. N. V., Sen, H. N., Tufail, A., & Lee, A. (2021) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2021.05.006 · Cited by 26
Xie, Y., Xie, J., Meijer, A. H., & Schaaf, M. J. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.618569 · Cited by 27
Dual Nature of Relationship between Mycobacteria and Cancer
Fol, M., Koziński, P., Kulesza, J., Białecki, P., & Druszczyńska, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158332 · Cited by 28
Evaluation of Berberine as an Adjunct to TB Treatment
Ozturk, M., Chia, J. E., Hazra, R., Saqib, M., Maine, R. A., Guler, R., Suzuki, H., Mishra, B. B., Brombacher, F., & Parihar, S. P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.656419 · Cited by 26
Prevalence of latent tuberculosis infection in Asian nations: A systematic review and meta‐analysis
Shrestha, A. B., Siam, I. S., Tasnim, J., Dahal, A., Roy, P., Neupane, S., Adhikari, A., Khanal, B., Ghimirie, R., Shrestha, D., et al. (2024) · Immunity Inflammation and Disease · doi:10.1002/iid3.1200 · Cited by 27
Primary immunodeficiency diseases in a tuberculosis endemic region: challenges and opportunities
Glanzmann, B., Uren, C., de Villiers, N., van Coller, A., Glashoff, R. H., Urban, M. F., Hoal, E. G., Esser, M., Möller, M., & Kinnear, C. J. (2018) · Genes and Immunity · doi:10.1038/s41435-018-0041-0 · Cited by 26
Estimating the prevalence of latent tuberculosis in a low-incidence setting: Australia
Dale, K., Trauer, J. M., Dodd, P. J., Houben, R. M. G. J., & Denholm, J. T. (2018) · European Respiratory Journal · doi:10.1183/13993003.01218-2018 · Cited by 26
Self-citationO’Shea, M. K., Fletcher, T. E., Müller, J., Tanner, R., Matsumiya, M., Bailey, J. W., Jones, J., Smith, S. G., Koh, G. C. K. W., Horsnell, W. G. C., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02893 · Cited by 26
Latent tuberculosis infection and renal transplantation – Diagnosis and management
Krishnamoorthy, S., Kumaresan, N., & Zumla, A. I. (2019) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2019.01.049 · Cited by 26
Romiti, R., Valenzuela, F., Chouela, E. N., Xu, W., Pangallo, B. A., Moriarty, S. R., Gürbüz, S., & Riedl, E. (2019) · British Journal of Dermatology · doi:10.1111/bjd.17604 · Cited by 25
Modeling of Mycobacterium tuberculosis dormancy in bacterial cultures
Batyrshina, Y., & Schwartz, Y. S. (2019) · Tuberculosis · doi:10.1016/j.tube.2019.05.005 · Cited by 26
Wong, N. S., Leung, C. C., Chan, K. C.-W., Chan, W. K., Lin, A. W. C., & Lee, S. S. (2019) · Scientific Reports · doi:10.1038/s41598-019-46570-5 · Cited by 25
Radhakrishnan, R. K., Thandi, R. S., Tripathi, D., Paidipally, P., McAllister, M. K., Mulik, S., Samten, B., & Vankayalapati, R. (2020) · JCI Insight · doi:10.1172/jci.insight.133788 · Cited by 24
Mandal, S., Bhatia, V., Sharma, M., Mandal, P. P., & Arinaminpathy, N. (2020) · BMC Medicine · doi:10.1186/s12916-020-01651-5 · Cited by 25
Vo, L. N. Q., Codlin, A. J., Huynh, H. B., To, T. D., Forse, R., Truong, V. V., Dang, H. M. T., Nguyen, B., Nguyen, L. H., Nguyen, T. D., et al. (2020) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed5030143 · Cited by 25
Sánchez‐Carvajal, J. M., Galán‐Relaño, Á., Ruedas‐Torres, I., Jurado‐Martos, F., Larenas‐Muñoz, F., Vera, E., Gómez‐Gascón, L., Cardoso‐Toset, F., Rodríguez-Gómez, I. M., Maldonado, A., et al. (2021) · Frontiers in Veterinary Science · doi:10.3389/fvets.2021.643111 · Cited by 25
Burel, J. G., Singhania, A., Dubelko, P., Müller, J., Tanner, R., Parizotto, E. A., Dedicoat, M. J., Fletcher, T. E., Dunbar, J., Cunningham, A. F., et al. (2021) · Tuberculosis · doi:10.1016/j.tube.2021.102127 · Cited by 24
Microfluidics as a Novel Technique for Tuberculosis: From Diagnostics to Drug Discovery
Molloy, A., Harrison, J., McGrath, J. S., Owen, Z., Smith, C. A., Liu, X., Li, X., & Cox, J. A. G. (2021) · Microorganisms · doi:10.3390/microorganisms9112330 · Cited by 24
Dal, N. K., Speth, M. T., Johann, K., Barz, M., Beauvineau, C., Wohlmann, J., Fenaroli, F., Gicquel, B., Griffiths, G. W., & Alonso‐Rodríguez, N. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.049147 · Cited by 25
Sagili, K. D., Muniyandi, M., Shringarpure, K. S., Singh, K., Kirubakaran, R., Rao, R., Tonsing, J., Sachdeva, K. S., & Tharyan, P. (2022) · Tropical Medicine & International Health · doi:10.1111/tmi.13808 · Cited by 25
Population-wide active case finding as a strategy to end TB
Nguyen, T. A., Teo, A. K. J., Zhao, Y., Quelapio, M., Hill, J., Morishita, F., Marais, B. J., & Marks, G. B. (2024) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2024.101047 · Cited by 25
Mycobacterium tuberculosis Reporter Strains as Tools for Drug Discovery and Development
Abramovitch, R. B. (2018) · IUBMB Life · doi:10.1002/iub.1862 · Cited by 26
Teklu, T., Legesse, M., Medhin, G., Zewude, A., Chanyalew, M., Zewdie, M., Wondale, B., Hailemariam, M., Pieper, R., & Ameni, G. (2018) · BMC Public Health · doi:10.1186/s12889-018-5149-7 · Cited by 25
The Mycobacterial HBHA Protein: A Promising Biomarker for Tuberculosis
Maio, F. D., Squeglia, F., Goletti, D., & Delogu, G. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666181029165805 · Cited by 27
Latent tuberculosis infection: recent progress and challenges in South Korea
Jeon, D. (2020) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2020.029 · Cited by 25
CRISPR-Based Diagnostics: A Potential Tool to Address the Diagnostic Challenges of Tuberculosis
Qi, Y., Li, K., Li, Y., Guo, D., Xu, J., Li, Y., & Gong, W. (2022) · Pathogens · doi:10.3390/pathogens11101211 · Cited by 24
Wu, X., Tan, G., Ma, J., Yang, J., Guo, Y., Lu, H., Ke, H., Li, M., Tang, Y., Sha, W., et al. (2023) · Emerging Microbes & Infections · doi:10.1080/22221751.2023.2261561 · Cited by 24
Transcriptomic Signatures of Progression to Tuberculosis Disease Among Close Contacts in Brazil
Mendelsohn, S. C., Andrade, B. B., Mbandi, S. K., Andrade, A. M. S., Muwanga, V. M., Figueiredo, M. C., Erasmus, M., Rolla, V. C., Thami, P. K., Cordeiro‐Santos, M., et al. (2024) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiae237 · Cited by 24
Huaman, M. A., Henson, D. M., Rondán, P. L., Ticona, E., Miranda, G., Kryscio, R. J., Mugruza, R., Aranda, E., Huaroto, C. T., Salazar, S. A., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202191 · Cited by 24
Latent tuberculosis among household contacts of pulmonary tuberculosis cases in Nairobi, Kenya
Odera, S., Mureithi, M., Aballa, A. O., Onyango, N., Anzala, O., & Oyugi, J. O. (2020) · Pan African Medical Journal · doi:10.11604/pamj.2020.37.87.21102 · Cited by 24
Xu, Y., Yang, Q., Zhou, J., Zhou, F., Hezhang, Y., Gao, Y., Shao, L., Shi, J., Ruan, Q., & Zhang, W. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01870-21 · Cited by 24
Ragonnet, R. R., Williams, B. M., Largen, A., Nasa, J., Jack, T., Langinlur, M. K., Ko, E., Rahevar, K., Islam, T., Denholm, J. T., et al. (2022) · International Journal of Epidemiology · doi:10.1093/ije/dyac045 · Cited by 22
End-point definition and trial design to advance tuberculosis vaccine development
García‐Basteiro, A. L., White, R. G., Tait, D. R., Schmidt, A. C., Rangaka, M. X., Quaife, M., Nemes, E., Mogg, R., Hill, P. C., Harris, R. C., et al. (2022) · European Respiratory Review · doi:10.1183/16000617.0044-2022 · Cited by 24
Shahrear, S., & Islam, A. B. M. M. K. (2022) · Molecular Diversity · doi:10.1007/s11030-022-10515-4 · Cited by 24
Agbota, G., Bonnet, M., & Lienhardt, C. (2023) · Pathogens · doi:10.3390/pathogens12030362
Ansari, M. A., Shoaib, S., Alomary, M. N., Ather, H., Ansari, S. M. A., Hani, U., Jamous, Y. F., Alyahya, S. A., Alharbi, J. N., Imran, M. A., et al. (2023) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2023.07.016 · Cited by 24
Wang, Y., He, X., Zheng, D., He, Q., Sun, L., & Jin, J. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.00577-23 · Cited by 23
Evaluating vaccination strategies for tuberculosis in endemic and non-endemic settings
Renardy, M., & Kirschner, D. E. (2019) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2019.02.020 · Cited by 24
Kagujje, M., Mubiana, M., Mwamba, E., & Muyoyeta, M. (2019) · BMC Public Health · doi:10.1186/s12889-019-7652-x · Cited by 24
Simmons, J. D., Peterson, G. J., Campo, M., Lohmiller, J., Skerrett, S. J., Tunaru, S., Offermanns, S., Sherman, D. R., & Hawn, T. R. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz541 · Cited by 24
Hu, X., Xing, B., Wang, W., Yang, P.-W., Sun, Y., Zheng, X., Shang, Y., Chen, F., Liu, N., Yang, L., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-73220-y · Cited by 24
Scordo, J. M., Aguillón-Durán, G. P., Ayala, D., Quirino-Cerrillo, A. P., Rodríguez-Reyna, E., Joya-Ayala, M., Mora-Guzmán, F., Ledezma-Campos, E., Villafañez, A., Schlesinger, L. S., et al. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.08.014 · Cited by 23
Torres, T. R., Brembilla, N. C., Langley, R. G. B., Warren, R. B., Thaçi, D., Kolios, A. G. A., Prinz, J. C., Londoño, Á., Nast, A., Santín, M., et al. (2024) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.20287 · Cited by 23
Kılıç, A., Zhou, X., Moon, Z., Hamada, Y., Duong, T., Layton, C., Jhuree, S., Abubakar, I., Rangaka, M. X., & Horne, R. (2025) · BMC Public Health · doi:10.1186/s12889-024-20868-0 · Cited by 23
Latent tuberculosis infection: diagnostic tests and when to treat
Petersen, E., Chakaya, J. M., Jawad, F. M., Ippolito, G., & Zumla, A. I. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30059-3 · Cited by 23
Sathkumara, H. D., Pai, S., Aceves-Sánchez, M. D. J., Ketheesan, N., Flores‐Valdez, M. A., & Kupz, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00532 · Cited by 23
Duffy, F. J., Thompson, E. G., Scriba, T. J., & Zak, D. E. (2019) · PLoS ONE · doi:10.1371/journal.pone.0219322 · Cited by 24
Prevention of tuberculosis in household members: estimates of children eligible for treatment
Hamada, Y., Glaziou, P., Sismanidis, C., & Getahun, H. (2019) · Bulletin of the World Health Organization · doi:10.2471/blt.18.218651 · Cited by 23
Cost-effectiveness of IGRA/QFT-Plus for TB screening of migrants in Oman
Abri, S. A., Kowada, A., Yaqoubi, F. A., Khalili, S. A., Ndunda, N., & Petersen, E. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.010 · Cited by 23
QuantiFERON-TB Gold Plus with Chemiluminescence Immunoassay: Do We Need a Higher Cutoff?
Bisognin, F., Lombardi, G., Re, M. C., & Monte, P. D. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.00780-20 · Cited by 23
Duffy, D., Nemes, E., Llibre, A., Rouilly, V., Musvosvi, M., Smith, N., Filander, E., Africa, H., Mabwe, S., Jaxa, L., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1562 · Cited by 24
Vaccination with BCGΔBCG1419c protects against pulmonary and extrapulmonary TB and is safer than BCG
Aceves-Sánchez, M. D. J., Flores‐Valdez, M. A., Pedroza-Roldán, C., Creissen, E., Izzo, L. S., Silva-Angulo, F., Dawson, C. C., Izzo, A. A., Bielefeldt‐Ohmann, H., Segura-Cerda, C. A., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-91993-8 · Cited by 23
Kafle, S., Basnet, A. K., Karki, K., Magar, M. T., Shrestha, S., & Yadav, R. S. (2021) · Cureus · doi:10.7759/cureus.17883 · Cited by 24
Vitamin D and the risk of latent tuberculosis infection: a systematic review and meta-analysis
Cao, Y., Wang, X., Liu, P., Su, Y., Yu, H., & Du, J. (2022) · BMC Pulmonary Medicine · doi:10.1186/s12890-022-01830-5 · Cited by 23
Ghorbanpoor, H., Dizaji, A. N., Akçakoca, İ., Blair, E. O., Öztürk, Y., Hoskisson, P. A., Kocagöz, T., Avcı, H., Corrigan, D. K., & Güzel, F. D. (2022) · Sensors and Actuators A Physical · doi:10.1016/j.sna.2022.113515 · Cited by 23
Molecular Imaging of Tuberculosis
Lawal, I. O., Abubakar, S., Ankrah, A. O., & Sathekge, M. M. (2022) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2022.07.001 · Cited by 23
Preventive Treatment for Household Contacts of Drug-Susceptible Tuberculosis Patients
Salazar‐Austin, N., Mulder, C., Hoddinott, G., Ryckman, T. S., Hanrahan, C. F., Velen, K., Chimoyi, L., Charalambous, S., & Chihota, V. N. (2022) · Pathogens · doi:10.3390/pathogens11111258 · Cited by 26
Programmatic management of tuberculosis preventive therapy: Past, present, future
Matteelli, A., Lovatti, S., Sforza, A., & Rossi, L. (2023) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2023.02.016 · Cited by 23
Challenges in childhood tuberculosis
Swaminathan, S., & Ramachandran, G. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.175 · Cited by 22
Doddam, S. N., Peddireddy, V., & Ahmed, N. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00712 · Cited by 23
Sun, Q., Shen, X., Wang, P., Ma, J., & Sha, W. (2019) · Aging · doi:10.18632/aging.102593 · Cited by 23
Dubé, J.-Y., Fava, V. M., Schurr, E., & Behr, M. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.714808 · Cited by 23
Oxlade, O., Trajman, A., Benedetti, A., Adjobimey, M., Cook, V. J., Fisher, D., Fox, G. J., Fregonese, F., Hadisoemarto, P. F., Hill, P. C., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-025831 · Cited by 22
Villa, S., Codecasa, L. R., Faccini, M., Pontello, M. M., Ferrarese, M., Castellotti, P. F., Senatore, S., Lamberti, A., Mazzola, E., Perno, C. F., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.00896-2019 · Cited by 22
Rajamanickam, A., Munisankar, S., Dolla, C. K., & Babu, S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225611 · Cited by 24
Shukla, R., Shukla, H., & Tripathi, T. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1758787 · Cited by 22
Dorjee, K., Topgyal, S., Tsewang, T., Tsundue, T., Namdon, T., Bonomo, E., Kensler, C., Lhadon, D., Choetso, T., Nangsel, T., et al. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003502 · Cited by 22
Rational laboratory testing in uveitis: A Bayesian analysis
McKay, K. M., Lim, L. L., & Gelder, R. N. V. (2021) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2021.02.002 · Cited by 24
Cost-effectiveness of the latent tuberculosis screening program for migrants in Stockholm Region
Shedrawy, J., Deogan, C. L., Öhd, J. N., Hergens, M., Bruchfeld, J., Jonsson, J., Siroka, A. M., & Lönnroth, K. (2021) · The European Journal of Health Economics · doi:10.1007/s10198-021-01265-5 · Cited by 22
Khoufi, E. A. A. (2021) · PubMed Central · doi:10.11604/pamj.2021.38.362.28110 · Cited by 26
Karbito, K., Susanto, H., Adi, M. S., Sulistiyani, S., Handayani, O. W. K., & Sofro, M. A. U. (2022) · Journal of Public Health in Africa · doi:10.4081/jphia.2022.2157 · Cited by 22
The immunogenetics of tuberculosis (TB) susceptibility
Sima, C. A. A. N., Smith, D., Petersen, D. C., Schurz, H., Uren, C., & Möller, M. (2022) · Immunogenetics · doi:10.1007/s00251-022-01290-5 · Cited by 22
TB Control in Humans and Animals in South Africa: A Perspective on Problems and Successes
Meiring, C., van Helden, P. D., & Goosen, W. J. (2018) · Frontiers in Veterinary Science · doi:10.3389/fvets.2018.00298 · Cited by 22
Chiacchio, T., Petruccioli, E., Vanini, V., Cuzzi, G., Massafra, U., Baldi, G., Navarra, A., Scrivo, R., Mastroianni, C. M., Sauzullo, I., et al. (2019) · Journal of Infection · doi:10.1016/j.jinf.2019.04.010 · Cited by 22
Manna, M. P. L., Orlando, V., Prezzemolo, T., Carlo, P. D., Cascio, A., Delogu, G., Poli, G., Sullivan, L. C., Brööks, A. G., Dieli, F., et al. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0261oc · Cited by 22
Kumar, N., Sharma, S., & Kaushal, P. S. (2024) · Nature Communications · doi:10.1038/s41467-024-44879-y · Cited by 20
Os Objetivos do Desenvolvimento Sustentável e a tuberculose no Brasil: desafios e potencialidades
Trajman, A., Saraceni, V., & Durovni, B. (2018) · Cadernos de Saúde Pública · doi:10.1590/0102-311x00030318 · Cited by 21
Different ways to transport ammonia in human and Mycobacterium tuberculosis NAD+ synthetases
Chuenchor, W., Doukov, T. I., Chang, K., Resto, M., Yun, C., & Gerratana, B. (2020) · Nature Communications · doi:10.1038/s41467-019-13845-4 · Cited by 21
Takeda, K., Nagai, H., Suzukawa, M., Sekiguchi, R., Akashi, S., Sato, R., Narumoto, O., Kawashima, M., Suzuki, J., Ohshima, N., et al. (2020) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2020.06.019 · Cited by 21
Panciera, M., Lence, E., Rodríguez, Á., Gracia, B., Aínsa, J. A., Marco‐Marín, C., Rubio, V., Correia, C. R. D., & González‐Bello, C. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114206 · Cited by 20
Recent Advances in Host-Directed Therapies for Tuberculosis and Malaria
Matteucci, K. C., Correa, A. A. D. S., & Costa, D. L. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.905278 · Cited by 23
Akalu, G. T., Tessema, B., & Petros, B. (2022) · PLoS ONE · doi:10.1371/journal.pone.0277145 · Cited by 21
Tao, B., Li, Z., Wang, Y., Wu, J., Shi, X., Shi, J., Liu, Q., & Wang, J. (2023) · Environmental Research · doi:10.1016/j.envres.2023.115695 · Cited by 21
Rego, K., Pereira, K., MacDougall, J. E., & Cruikshank, W. W. (2017) · Tuberculosis · doi:10.1016/j.tube.2017.12.005 · Cited by 21
Zítko, J., Janďourek, O., Paterová, P., Navrátilová, L., Kuneš, J., Vinšová, J., & Doležal, M. (2018) · MedChemComm · doi:10.1039/c8md00056e · Cited by 21
Thomas, Κ., Lazarini, A., Kaltsonoudis, E., Drosos, A. A., Papalopoulos, I., Sidiropoulos, P. I., Katsimbri, P., Boumpas, D. T., Tsatsani, P., Gazi, S., et al. (2018) · Mediterranean Journal of Rheumatology · doi:10.31138/mjr.29.1.27 · Cited by 21
Friends and foes of tuberculosis: modulation of protective immunity
Brighenti, S., & Joosten, S. A. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12778 · Cited by 20
Metformin in tuberculosis: beyond control of hyperglycemia
Oglesby, W., Kara, A. M., Granados, H., & Cervantes, J. (2019) · Infection · doi:10.1007/s15010-019-01322-5 · Cited by 21
Introducing risk inequality metrics in tuberculosis policy development
Gomes, M. G. M., de Oliveira, J. F., Bertolde, A. I., Ayabina, D. V., Nguyễn, A. T., Maciel, E. L. N., Duarte, R., Nguyen, B. H., Shete, P. B., & Lienhardt, C. (2019) · Nature Communications · doi:10.1038/s41467-019-10447-y · Cited by 21
Rebeiro, P. F., Cohen, M. J., Ewing, H., Figueiredo, M. C., Peetluk, L. S., Andrade, K. B., Eakin, M. C., Zechmeister, E. J., & Sterling, T. R. (2020) · BMC Public Health · doi:10.1186/s12889-020-09053-1 · Cited by 21
Luo, Y., Xue, Y., Xu, Y., Lin, Q., Tang, G., Mao, L., Song, H., Wang, F., & Sun, Z. (2020) · International Journal of Clinical Practice · doi:10.1111/ijcp.13831 · Cited by 21
Cioboată, R., Vasile, C. M., Bălteanu, M. A., Georgescu, D. E., Toma, C., Drăcea, A., & Nicolosu, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010418 · Cited by 20
Paired analysis of host and pathogen genomes identifies determinants of human tuberculosis
Luo, Y., Huang, C., Howard, N. C., Wang, X., Liu, Q., Li, X., Zhu, J., Amariuta, T., Asgari, S., Ishigaki, K., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54741-w · Cited by 20
Fiske, C. T., Blackman, A., Maruri, F., Rebeiro, P. F., Huaman, M. A., Kator, J. L., Algood, H. M. S., & Sterling, T. R. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-3958-7 · Cited by 20
Loureiro, R. B., Maciel, E. L. N., Caetano, R., Peres, R. L., Fregona, G. C., Golub, J. E., & Braga, J. U. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225197 · Cited by 20
Metadata
- Authors
- Houben, R. M. G. J., & Dodd, P. J.
- Affiliations
- London School of Hygiene & Tropical Medicine (GB)
- University of Sheffield (GB)
- Corresponding author
- Houben, Rein M. G. J.
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-10-25
- Volume
- 13
- Issue
- 10
- Pages
- e1002152
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC5079585
- OpenAlex
- W2533230523
- Cited by
- 2,054
- References
- 26
- Citations by year
- 2026: 160 · 2025: 259 · 2024: 242 · 2023: 243 · 2022: 208 · 2021: 237 · 2020: 257 · 2019: 205 · 2018: 167 · 2017: 67 · 2016: 5
- FWCI
- 22.73
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Bill and Melinda Gates Foundation (US) (OPP1084276)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › HIV, TB, and STIs Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Keywords
- latent tuberculosis infection, global burden of disease, annual risk of infection, isoniazid-resistant tuberculosis, recent infection, End TB Strategy, Gaussian process regression, WHO regions, tuberculosis control, uncertainty quantification, demography
- MeSH terms
- Antitubercular Agents, Humans, Isoniazid, Mycobacterium tuberculosis, Risk, Global Health, Incidence, Prevalence, Tuberculosis, Multidrug-Resistant, Latent Tuberculosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
